INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 August 2014
Net Assets |
£215m |
Net Assets per share |
396p |
Share price |
315p |
Total value of unquoted investments |
£18m |
Total number of portfolio companies |
89 |
Top Ten Holdings
Company Name |
% NAV |
Gilead |
9.8 |
Alexion |
7.3 |
Biogen |
7.1 |
Celgene |
6.9 |
Amgen |
6.1 |
Illumina |
3.9 |
Regeneron |
3.7 |
Biomarin |
3.3 |
Actelion |
3.0 |
Chimerix |
3.0 |
|
----------- |
Total |
54.1 |
Portfolio Profitability |
% NAV |
Profitable |
62 |
Turning Profitable 2015 |
6 |
Unprofitable |
32 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
United States & Canada |
89 |
Europe & UK |
11 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
92 |
Unquoted |
8 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 SEPTEMBER 2014